70 results on '"Kim, Choung Soo"'
Search Results
2. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
3. Dr. Answer AI for Prostate Cancer: Intention to Use, Expected Effects, Performance, and Concerns of Urologists
4. Impact of positive surgical margin on biochemical recurrence in localized prostate cancer
5. Validation of the European association of urology biochemical recurrence risk groups after radical prostatectomy in an Asian cohort and suggestions for refinement
6. Differential contribution of the factors determining long-term renal function after partial nephrectomy over time
7. Prostate cancer trajectory-map: clinical decision support system for prognosis management of radical prostatectomy
8. Association of Bacillus Calmette–Guerin shortages with bladder cancer recurrence: A single-center retrospective study
9. Epigenetic regulation of miR-29a/miR-30c/DNMT3A axis controls SOD2 and mitochondrial oxidative stress in human mesenchymal stem cells
10. Width of spared neurovascular bundle after robot-assisted laparoscopic prostatectomy in patients with prostate cancer: is it a reliable factor for predicting postoperative sexual outcome?
11. Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease?
12. Application of 3-D Printed Kidney Model in Partial Nephrectomy for Predicting Surgical Outcomes: A Feasibility Study
13. Impact of lymph node dissection in radical cystectomy for bladder cancer: How many vs how far?
14. Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer
15. Report of the third Asian Prostate Cancer study meeting
16. Clinical outcomes and costs of robotic surgery in prostate cancer: a multiinstitutional study in Korea
17. Prognostic factors of oncologic outcomes in metastatic chemotherapy-naïve castration-resistant prostate cancer treated with enzalutamide in actual clinical practice in East Asia
18. Declining incidence of benign lesions among small renal masses treated with surgery: Effect of diagnostic tests for characterization
19. Discrimination of local recurrence after radical prostatectomy: value of diffusion-weighted magnetic resonance imaging
20. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma
21. Predictors of female genital organ involvement in radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective analysis of 112 female patients
22. Neurovascular bundle size measured on 3.0-T magnetic resonance imaging is associated with the recovery of erectile function after robot-assisted radical prostatectomy
23. Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting
24. Does Ureteral Catheter Insertion Decrease the Risk of Urinary Leakage After Partial Nephrectomy in Patients With Renal Cell Carcinoma?
25. High throughput differential identification of TMPRSS2-ERG fusion genes in prostate cancer patient urine
26. Is suspicious upstaging on multiparametric magnetic resonance imaging useful in improving the reliability of Prostate Cancer Research International Active Surveillance (PRIAS) criteria? Use of the K-CaP registry
27. Prognostic heterogeneity in T3aN0M0 renal cell carcinoma according to the site of invasion
28. Changes in Weight and Metabolic Syndrome Are Associated With Prostate Growth Rate Over a 5-Year Period
29. Reply by the Authors
30. Impact of Tumor Location on Local Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma: Implications for Adjuvant Radiotherapy
31. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy
32. Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor- β (PDGF- β ), and PDGF- β receptor expression in papillary renal cell carcinoma
33. Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study.
34. Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study
35. The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.
36. The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
37. Asia prostate cancer study (A-CaP Study) launch symposium
38. Bone marrow–derived mesenchymal stromal cell therapy in a rat model of cavernous nerve injury: Preclinical study for approval
39. New drugs in prostate cancer
40. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy
41. Human turbinate mesenchymal stromal cell sheets with bellows graft for rapid tracheal epithelial regeneration
42. Epidemiology of prostate cancer in South Korea
43. Kidney Laterality and the Safety of Hand-assisted Live Donor Nephrectomy: Review of 1000 Consecutive Cases at a Single Center
44. Prevalence of High-grade or Insignificant Prostate Cancer in Korean Men With Prostate-specific Antigen Levels of 3.0-4.0 ng/mL
45. Efficacy and safety of degarelix in Korean patients with prostate cancer requiring androgen deprivation therapy: Open-label multicenter phase III study
46. Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management
47. Bone Mineral Density in Prostate Cancer: A Comparative Study of Patients With Prostate Cancer and Healthy Controls Using Propensity Score Matching
48. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma
49. Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma
50. Response Evaluation Criteria in Solid Tumors Response of the Primary Lesion in Metastatic Renal Cell Carcinomas Treated With Sunitinib: Does the Primary Lesion Have to Be Regarded as a Target Lesion?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.